Latest Cancer News

Gilteritinib Approved for Advanced Acute Myeloid Leukemia (AML) with a FLT3 Mutation (11-29-2018)
The U.S. Food and Drug Administration approved Xospata (gilteritinib) for treatment of adult patients who have recurrent or refractory acute myeloid leukemia (AML) with a FLT3 mutation. About Xospata Xospata... Continue Reading

Tissue “Agnostic” Genomic Based Treatment With Vitrakvi and Keytruda – A Paradigm Shift in Cancer Treatment (11-28-2018)
The US Food and Drug Administration (FDA) on Monday approved a new precision cancer medicine Vitrakvi (larotrectinib) for the treatment of adult and pediatric solid tumors that have a targetable biomarker... Continue Reading

FDA Approves Venclexta Combination for AML in Adults (11-26-2018)
The Food and Drug Administration granted accelerated approval to Venclexta (venetoclax) in combination with azacitidine or decitabine or low-dose cytarabine for the treatment of newly-diagnosed acute myeloid... Continue Reading

More Cancer News

Locations

VIRGINIA BEACH OFFICE
1200 First Colonial Road
Suite 204
Virginia Beach, VA 23454
Phone (757)363-8212
Fax (757)363-2246
View Map

CHESAPEAKE OFFICE
Chesapeake Medical Center
110 Wimbledon Square
Suite E
Chesapeake, VA 23320
Phone (757)436-2995
Fax (757)436-2912
View Map

SUFFOLK OFFICE
Cancer Specialists of Tidewater
5839 Harbour View Blvd.,
Suite 100
Suffolk, VA 23435
Phone (757)397-4200
Fax (757)397-3872
View Map